Case File
efta-efta00920611DOJ Data Set 9OtherFrom: "Erdoes, Mary E"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00920611
Pages
1
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Erdoes, Mary E"
To: [email protected] <[email protected]>
CC: "Staley, Jes"
Subject: Re:
Date: Wed, 28 Sep 2011 11:21:23 +0000
Getting on flight back to nyc.
Will discuss with jes tonight
From: Jeffrey Epstein [[email protected]]
Sent: Wednesday, September 28, 2011 05:56 AM
To: Erdoes, Mary E; Staley, Jes
Subject:
The proposal that Bill gets reduced fees , and then channels the discount to me, is an idea that is still born for
many of the reasons that we discussed. I think the solution is quite simple. JPM engage an entity , ( a law firm ,
bank, trust co .etc ) that it pays a percentage of its profits on the DAF every year. This amount could be
supplemented or decreased by other business directly related to that entity ( kazzak govt for example ).. The
only issues would be what type of entity and the relevant rules and reporting requirements. and the amounts and
how they are calculated. AS I had proposed , I stand willing to pay my share of costs . legal etc. / An early
iteration was that A bill entitty simply hired JPM to do the administration for his DAF. I didn;t think that was
the right structure, as the profits would mostly stay in his entity, but maybe that can be revisited.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jea®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.com/pages/disclosures/email.
EFTA00920611
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.